Skip to main content
Oxidative Medicine and Cellular Longevity logoLink to Oxidative Medicine and Cellular Longevity
. 2020 Aug 24;2020:7059751. doi: 10.1155/2020/7059751

Corrigendum to “Dexmedetomidine Postconditioning Alleviates Hypoxia/Reoxygenation Injury in Senescent Myocardial Cells by Regulating lncRNA H19 and m6A Modification”

Xuan Zhang 1,2, Qiang Fu 1, Longhe Xu 1, Yitian Yang 1, Weixing Zhao 1, Yunliang Zhang 1, Weidong Mi 1,, Hao Li 1,
PMCID: PMC7479448  PMID: 32936090

In the article titled “Dexmedetomidine Postconditioning Alleviates Hypoxia/Reoxygenation Injury in Senescent Myocardial Cells by Regulating lncRNA H19 and m6A Modification” [1], the author order in the author list was incorrect, where

“Xuan Zhang1,2, Qiang Fu1, Longhe Xu1, Yitian Yang1, Weixing Zhao1, Yunliang Zhang1, Hao Li1, and Weidong Mi1”should have read as follows:

“Xuan Zhang1,2, Qiang Fu1, Longhe Xu1, Yitian Yang1, Weixing Zhao1, Yunliang Zhang1, Weidong Mi1, and Hao Li1

The correct author order is also shown above in the author information.

Contributor Information

Weidong Mi, Email: wwdd1962@aliyun.com.

Hao Li, Email: lihao301@126.com.

References

  • 1.Zhang X., Fu Q., Xu L., et al. Dexmedetomidine postconditioning alleviates hypoxia/reoxygenation injury in senescent myocardial cells by regulating lncRNA H19 and m6A modification. Oxidative Medicine and Cellular Longevity. 2020;2020:13. doi: 10.1155/2020/9250512.9250512 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Oxidative Medicine and Cellular Longevity are provided here courtesy of Wiley

RESOURCES